Canada · Health Canada Drug Product Database
ACEL-P - SUS IM 300HAU
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 43147
- DIN
- 02215071
- Form
- Suspension
- Company as listed by source
- LEDERLE LABS, DIVISION OF AMERICAN CYANAMID CO
- Source status
- Cancelled Post Market (2001-05-22)
- Source last updated
- 2025-03-22
Source-listed ingredients
- ACELLULAR PERTUSSIS VACCINE — 300 UNIT — per .5 ML
These values do not establish equivalence or a dose recommendation.
Packages
- Acellular Pertussis Vaccine Adsorbed [0.5 Ml Vial]
Source and coverage
Open Health Canada Drug Product Database →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse Canada records →